Skip to main content
. 2021 May 13;11:10190. doi: 10.1038/s41598-021-89712-4

Figure 2.

Figure 2

Development and relative reduction in bilirubin levels in patients with CytoSorb and ADVOS therapy. d–1: day before treatment, d0: shortly before treatment, d1: directly after treatment, CS: CytoSorb, ADV: advanced organ support; orange line represents the median, grey boxes the interquartile range and the whiskers are limited to 1.5 times the interquartile range.